Trials / Unknown
UnknownNCT03505840
The Value of Placental Vascularization and Placental Volume in Pregnancy in APLS
TheValue of Placental Vascularization Indices and Placental Volume in Pregnancies With Antiphospholipid Syndrome for Prediction of Neonatal Outcome"
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Aljazeera Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Antiphospholipid antibodies are autoantibodies directed against phospholipid-binding proteins. Among these groups of antibodies, lupus anticoagulant (LA) and anticardiolipin antibodies (aCL)
Detailed description
APLS can be primary when no evidence of autoimmune disease is found, or secondary to autoimmune processes like systemic lupus erythematous (SLE) in a 40% of the cases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Ultrasound with Doppler and 3D technology | ultrasound will be made to pregnant females in 3rd trimester with doppler and 3D technology |
Timeline
- Start date
- 2018-04-24
- Primary completion
- 2020-09-04
- Completion
- 2020-10-10
- First posted
- 2018-04-23
- Last updated
- 2020-01-27
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03505840. Inclusion in this directory is not an endorsement.